2025 News & Features
-
Eye prosthesis is the first to restore sight lost to macular degeneration
In a Stanford Medicine-led clinical trial of a wireless retinal prosthesis, people with advanced macular degeneration regained enough vision to read books and subway signs.
-
 copy.jpg)
First FDA-approved MacTel treatment available at the Byers Eye Institute
The Byers Eye Institute is proud to offer the only FDA-approved treatment for patients diagnosed with macular telangiectasia type 2, known as MacTel. Make an appointment at: 650.723.6995. No center has implanted more of these devices in patients.
-
Unraveling mysteries of human behavior
Andreas Tolias, PhD, was named a primary investigator in 10-year project to shed new light on human behavior and cognition…
-
Bridging the data gap in pediatric ophthalmology
A Byers Eye Institute-led team was awarded to map eye exam data and harness it for clinical research.
-
AI models of the brain could serve as ‘digital twins’ in research
In a new study, researchers created an AI model of the mouse visual cortex that predicts neuronal responses to visual images.
-
Kuldev Singh, MD, MPH, on Cataract Coach
Kuldev Singh, MD, MPH, as been an ophthalmologist at Stanford University for more than three decades and is a recognized expert in glaucoma clinical care.
-
New research uncovers promising treatment for neurodegenerative diseases like ALS, glaucoma
The treatment approach targets diseases that cause degeneration of the axons in the central nervous system.
-
Silicon Chips on the Brain
Fabricated as a single chip, the new implant is orders of magnitude faster and smaller than today’s state-of-the-art brain-computer interfaces, offering an opportunity for more efficacious treatment of a number of neurological conditions.